18F-FDG PET作为自身免疫性胶质纤维酸性蛋白星形细胞病的诊断与监测工具:一例病例报告
一例58岁女性自身免疫性胶质纤维酸性蛋白(GFAP)星形细胞病患者,在利妥昔单抗治疗前后接受18F-FDG PET检查。治疗前PET显示脑炎伴弥漫性小脑和脑干高代谢及全脊髓炎;利妥昔单抗引入4个月后闪烁显像显著改善并伴症状改善。本病例报告强调18F-FDG PET在抗GFAP星形细胞病诊断、探索其他病因和随访中的有用性。
要点
- 58岁女性抗GFAP星形细胞病,MRI提示脑膜脑脊髓炎,抗GFAP阳性确诊。
- 治疗前18F-FDG PET显示脑炎伴弥漫性小脑和脑干高代谢及全脊髓炎。
- 利妥昔单抗治疗4个月后PET显著改善,伴症状改善。
核心结论
- 本病例报告强调18F-FDG PET在抗GFAP星形细胞病诊断、探索其他病因和随访中的有用性。
研究设计与样本
- 病例报告:一例58岁女性自身免疫性GFAP星形细胞病患者,在利妥昔单抗(抗CD20单克隆抗体)治疗前后行18F-FDG PET检查。
主要发现
- 治疗前闪烁显像显示脑炎伴弥漫性小脑和脑干高代谢及全脊髓炎。
- 利妥昔单抗引入4个月后闪烁显像显著改善,伴症状改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 58-year-old woman with autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy was explored using [ 18 F]-fluorodeoxyglucose ([ 18 F]-FDG) positron emission tomography (PET) before and after treatment with rituximab, an anti-CD20 monoclonal antibody. GFAP astrocytopathy was first suggested by magnetic resonance imaging showing a meningoencephalomyelitis, confirmed by anti-GFAP positivity. Before treatment, scintigraphic images evidenced encephalitis associated with diffuse cerebellar and brainstem hypermetabolism and panmyelitis. Significant scintigraphic improvement was observed 4 months after rituximab introduction, associated with an improvement of symptoms. This case report highlights the usefulness of [ 18 F]-FDG PET in anti-GFAP astrocytopathy diagnosis, exploration of additional etiologies, and follow-up.
引用
- Dubois J, Paunet T, Verbeke S, et al. [ 18 F]-FDG PET as a Diagnostic and Monitoring Tool in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Case Report. Clin Nucl Med. 2025. PMID: 40938181. doi:10.1097/RLU.0000000000006118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。